Show
CDC.gov Privacy SettingsWe take your privacy seriously. You can review and change the way we collect information below. Performance Cookies Checkbox These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Functional Cookies Checkbox Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Campaign Cookies Checkbox Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Social Media Cookies Checkbox Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties. Alzheimer’s disease, the most common type of dementia, is an irreversible, progressive brain disease that affects over 6 million adults. It is the fifth leading cause of death for those aged 65 or older. Alzheimer’s disease and other dementias slowly destroy the brain. They lead to cognitive declines, such as memory loss, language problems, or poor executive function, and functional declines, such as less ability to do daily activities and self-care. In some cases, dementias can lead to behavioral and personality changes, such as depression, paranoia, hallucinations, delusions, or agitation. People with cognitive decline may find it hard to stay healthy or manage other chronic conditions. Early detection of cognitive decline, including Alzheimer’s and other dementias, provides an opportunity to manage other chronic health conditions and create health care plans. Surveillance and ResourcesCDC’s Alzheimer’s Disease and Healthy Aging Program works with partners and states to gather information on self-reported cognitive decline and caregiving among adults through the Behavioral Risk Factor Surveillance System (BRFSS). CDC developed an interactive data portal and a series of statistical briefs and infographics to help all users translate the data to action. Healthy Brain Initiative and Public Health Road MapsThe Healthy Brain Initiative improves understanding of brain health as a central part of public health practice by:
The initiative also promotes the use of the Healthy Brain Initiative Road Map Series: State and Local Public Health Partnerships to Address Dementia: The 2018–2023 Road Map and the Healthy Brain Initiative Road Map for Indian Country. These publications describe actions that state and local public health agencies and their partners can take to promote cognitive health, address cognitive impairment, and respond to the needs of caregivers. Building Our Largest Dementia Infrastructure (BOLD)The BOLD Infrastructure for Alzheimer’s Act became law on December 31, 2018. BOLD activities are designed to promote the use of CDC’s Healthy Brain Initiative Road Map Series to create a uniform national public health infrastructure to increase early detection and diagnosis, reduce risk, prevent hospitalizations, and support dementia caregivers. The BOLD Act:
In 2020, CDC funded the first three BOLD Public Health Centers of Excellence and 16 BOLD Public Health Programs. Seven additional BOLD Public Health Programs were funded in 2021 for a total of 23.
'Caring for the Elderly' - an Overview of Aged Care Support and Services in AustraliaE-Brief: Online Only issued 27 February 2003; updated 30 April 2003Greg McIntosh, Analysis and Policy |